Medicine

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)

M. Dinis-Ribeiro, M. Areia, A. Vries, R. Marcos-Pinto, M. Monteiro-Soares, A. O’Connor, Carla Pereira, P. Pimentel-Nunes, R. Correia, A. Ensari, J. Dumonceau, J. Machado, G. Macedo, P. Malfertheiner, T. Matysiak-Budnik, F. Mégraud, K. Miki, C. O'Morain, R. Peek, T. Ponchon, A. Ristimäki, A. Ristimäki, B. Rembacken, F. Carneiro, E. Kuipers

2011.1.1VIRCHOWS ARCHIV

DOI: 10.1007/s00428-011-1177-8

tlooto Summary

The recommendations emphasize the increased cancer risk in patients with gastric atrophy and metaplasia and the need for adequate staging in the case of high-grade dysplasia, and they focus on treatment and surveillance indications and methods.

Abstract

Abstract is not available.

Citation format

DINIS-RIBEIRO, M., et al. Management of precancerous conditions and lesions in the stomach (MAPS): Guideline from the European society of gastrointestinal endoscopy (ESGE), European helicobacter study group (EHSG), European society of pathology (ESP), and the sociedade portuguesa de endoscopia digestiva (SPED). VIRCHOWS ARCHIV, 2011, 460: 19–46.